Table 2.
ALL (n=126) | Symptomatic (n=66) | Asymptomatic (n=60) | p value | |
---|---|---|---|---|
Age | 61.5±10.0 | 61.7±10.5 | 61.4±9.4 | 0.86 |
Sex (male) | 82 (65.1%) | 50 (75.8%) | 32 (53.3%) | <0.001* |
Diabetes | 42 (33.3%) | 23 (34.8%) | 19 (31.7%) | 0.71 |
Smoking | 35 (27.8%) | 25 (37.9%) | 10 (16.7%) | <0.001* |
Hypertension | 101(80.2%) | 52 (78.8%) | 49 (81.7%) | 0.69 |
Hyperlipidemia | 65 (51.6%) | 38 (57.6%) | 27 (45.0%) | 0.16 |
Coronary Artery Disease | 5 (4.0%) | 3 (4.5%) | 2 (3.3%) | 0.73 |
Pre-admission Aspirin use | 31 (24.6%) | 21 (31.8%) | 10 (16.7%) | 0.06 |
Pre-admission Statin use | 17 (13.5%) | 10 (15.2%) | 7 (11.7%) | 0.57 |
NIHSS score (median and range) | 1 (0,11) | 2 (0,11) | 0 (0,4) | <0.001* |
Degree of Stenosis (%) | 52.6±15.8 | 52.4±15.5 | 52.8±16.1 | 0.88 |
Enhancement Percentage (%) | 17.4± 28.4 | 25.5±26.1 | 8.5±28.5 | <0.001* |
Intraplaque Haemorrhage | 22 (17.5%) | 21 (31.8%) | 1 (1.7%) | <0.001* |
Minimum Lumen Area (mm2) | 3.2±2.7 | 3.7±2.8 | 2.7±2.6 | 0.04* |
Plaque Burden (%) | 84.0±9.1 | 83.6±9.8 | 84.4±8.2 | 0.62 |
NIHSS: National Institute of Health Stroke Scale
Statistically significant